Literature DB >> 6288769

Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus.

M C Jordan, V L Mar.   

Abstract

Cytomegalovirus (CMV) is a major pathogen in the compromised host where many infections result from activation of latent virus. Because latent CMV infection has been difficult to study in humans, murine models have been developed and investigated. Here, we describe the events involved in activation of latent murine CMV (MCMV) from spleen explants in vitro. Infectious virus was no longer detectable in murine organs 4 mo after inoculatioN of 10(5) plaque-forming units of MCMV. 8-10 d after establishment of spleen explants, phagocytic macrophages covered 70-80% of the surface of tissue culture dishes, and lymphocytes were continuously released, reaching titers of 10(6) cells/ml. MCMV was produced spontaneously after 12-18 d from spleen explant cultures of 33 of 34 mice. Virus replicated to titers above 10(4) plaque-forming units/ml, remained at that level for 4-5 wk, and gradually disappeared as macrophages were lysed. Although MCMV was shown to be replicating in macrophages, these cells were never found to be the source of latent virus. Cell separation studies indicated that latent virus was initially released from 70% of lymphocyte cultures and was associated with the B cell enriched fraction. We conclude that MCMV establishes nonreplicating dormant infection in B lymphocytes, activates from these cells in spleen explant cultures, and is augmented in titer by replication in permissive macrophages.

Entities:  

Mesh:

Year:  1982        PMID: 6288769      PMCID: PMC370284          DOI: 10.1172/jci110672

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells.

Authors:  A Adams; T Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Cytomegalovirus infection in a volunteer blood donor population.

Authors:  R C Kane; W E Rousseau; G R Noble; G E Tegtmeier; H Wulff; H B Herndon; T D Chin; W L Bayer
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

4.  Evidence that neurons harbor latent herpes simplex virus.

Authors:  M L Cook; V B Bastone; J G Stevens
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

5.  Recovery of herpes-simplex virus from human trigeminal ganglions.

Authors:  J R Baringer; P Swoveland
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

6.  Recovery of herpes simplex virus from human sacral ganglions.

Authors:  J R Baringer
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

7.  Herpesvirus hominis: isolation from human trigeminal ganglion.

Authors:  F O Bastian; A S Rabson; C L Yee; T S Tralka
Journal:  Science       Date:  1972-10-20       Impact factor: 47.728

8.  Role of macrophages in resistance to murine cytomegalovirus.

Authors:  M K Selgrade; J E Osborn
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

9.  Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.

Authors:  L B Olding; F C Jensen; M B Oldstone
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

10.  In vitro synthesis and secretion of lysozyme by mononuclear phagocytes.

Authors:  S Gordon; J Todd; Z A Cohn
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  28 in total

1.  Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.

Authors:  N K Grzimek; D Dreis; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.

Authors:  J A Mercer; C A Wiley; D H Spector
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Immune evasion proteins enhance cytomegalovirus latency in the lungs.

Authors:  Verena Böhm; Christof K Seckert; Christian O Simon; Doris Thomas; Angélique Renzaho; Dorothea Gendig; Rafaela Holtappels; Matthias J Reddehase
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

4.  Focal transcriptional activity of murine cytomegalovirus during latency in the lungs.

Authors:  S K Kurz; M Rapp; H P Steffens; N K Grzimek; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 5.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

Review 6.  Human herpesviruses: a consideration of the latent state.

Authors:  J G Stevens
Journal:  Microbiol Rev       Date:  1989-09

7.  DMSO induces reactivation of cytomegalovirus in vitro from spleens of latently infected mice. Brief report.

Authors:  S Blackett; A Gupta; C A Mims
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Cellular defenses against Toxoplasma gondii in newborns.

Authors:  C B Wilson; J E Haas
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus.

Authors:  C A Stoddart; R D Cardin; J M Boname; W C Manning; G B Abenes; E S Mocarski
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice.

Authors:  T M Collins; M R Quirk; M C Jordan
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.